TB-500 is a synthetic peptide corresponding to the active binding region of thymosin beta-4, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 3 to 7 business days of order, depending on your state.
Specifications - Compound: TB-500 (thymosin beta-4 fragment). Sequence: Ac-Ser-Asp-Lys-Pro. Format: lyophilised powder. Quantity: 5mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - TB-500 represents the actin-binding domain of thymosin beta-4, a naturally occurring protein present in most mammalian cell types. Research interest centres on actin sequestration and cytoskeletal dynamics in cultured cell models, cell migration behaviour in in-vitro assays, and angiogenesis pathway studies. Because the active fragment is considerably smaller than full-length thymosin beta-4, it is often used in comparative studies examining how peptide length affects stability and diffusion. Genesis Peptides supplies TB-500 in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.